Butofilolol

CAS No. 58930-32-8

Butofilolol( —— )

Catalog No. M35470 CAS No. 58930-32-8

Butofilolol is a novel beta-blocker with antihypertensive activity and can be used to study hypertension.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
25MG 1444 In Stock
50MG 1841 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Butofilolol
  • Note
    Research use only, not for human use.
  • Brief Description
    Butofilolol is a novel beta-blocker with antihypertensive activity and can be used to study hypertension.
  • Description
    Butofilolol is a potent β-blocking agent used in the research of hypertension.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58930-32-8
  • Formula Weight
    311.392
  • Molecular Formula
    C17H26FNO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCC(=O)c1cc(F)ccc1OCC(O)CNC(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Toussain P, et al. Long-term hypotensive treatment by butofilolol. Ann Cardiol Angeiol (Paris). 1983 Jun;32(4):277-83.?
molnova catalog
related products
  • Milveterol

    Milveterol (GSK 159797) is a potent, selective long-acting β2 adrenoceptor agonist with pEC50 of 10.2 in cell-based assays.

  • Olodaterol hydrochlo...

    Olodaterol hydrochloride (BI1744 CL) is a potent, selective long-acting β2 adrenoceptor agonist with EC50 of 1.4 nM for hβ2.

  • Arotinolol hydrochlo...

    Arotinolol hydrochloride(Arotinolol HCl) is a non-selective α/β-adrenergic receptor blocker.Arotinolol hydrochloride inhibits the binding of the radioligand 125I-ICYP to the 5HT1B-hydroxytryptamine receptor.